Hong Kong stocks abnormal | Junshi Biosciences (01877.HK) rose by over 6% again. Junshi's two new indications approved, the company accelerating the progress of clinical pipelines under research.

According to the "Securities Times" app, Junshi Biosciences (01877.HK) rose more than 6% again, as of the time of writing, rising 5.72% to 19.22 Hong Kong dollars, with a turnover of 90.3852 million Hong Kong dollars.